These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 28826094)

  • 1. Up-regulation of HCRP1 inhibits proliferation and invasion in glioma cells via suppressing the ERK and AKT signaling pathways.
    Xu CY; Li ZJ; Hu WZ
    Biomed Pharmacother; 2017 Nov; 95():31-36. PubMed ID: 28826094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.
    Xu H; Miao ZF; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Zhang JY; Liu XY; Wu JH; Xu HM
    Virchows Arch; 2017 Dec; 471(6):743-751. PubMed ID: 28963677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.
    Wu Y; Yang Y; Xian YS
    Chem Biol Interact; 2019 Aug; 308():357-363. PubMed ID: 31152734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCRP1 regulates proliferation, invasion, and drug resistance via EGFR signaling in prostate cancer.
    Sun L; Lü J; Ding S; Bi D; Ding K; Niu Z; Liu P
    Biomed Pharmacother; 2017 Jul; 91():202-207. PubMed ID: 28458158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased HCRP1 promotes breast cancer metastasis by enhancing EGFR phosphorylation.
    Yang W; Wang JG; Wang Q; Qin Y; Lin X; Zhou D; Ren K; Hou C; Xu J; Liu X
    Biochem Biophys Res Commun; 2016 Aug; 477(2):222-8. PubMed ID: 27311861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth-regulatory protein HCRP1/hVps37A is a subunit of mammalian ESCRT-I and mediates receptor down-regulation.
    Bache KG; Slagsvold T; Cabezas A; Rosendal KR; Raiborg C; Stenmark H
    Mol Biol Cell; 2004 Sep; 15(9):4337-46. PubMed ID: 15240819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.
    Wittinger M; Vanhara P; El-Gazzar A; Savarese-Brenner B; Pils D; Anees M; Grunt TW; Sibilia M; Holcmann M; Horvat R; Schemper M; Zeillinger R; Schöfer C; Dolznig H; Horak P; Krainer M
    Clin Cancer Res; 2011 Dec; 17(24):7816-27. PubMed ID: 22016507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of TIP30 inhibits the growth and invasion of glioma cells.
    Hu Y; Chen F; Liu F; Liu X; Huang N; Cai X; Sun Y; Li A; Luo R
    Mol Med Rep; 2016 Jan; 13(1):605-12. PubMed ID: 26718891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
    Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer.
    Tomasich E; Topakian T; Heller G; Udovica S; Krainer M; Marhold M
    Transl Res; 2021 Apr; 230():21-33. PubMed ID: 33197651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.
    Ma W; Na M; Tang C; Wang H; Lin Z
    Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G; Shiras A; Shanmuganandam K; Shastry P
    Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCRP1 inhibits TGF-β induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang W; Wang JG; Xu J; Zhou D; Ren K; Hou C; Chen L; Liu X
    Int J Oncol; 2017 Apr; 50(4):1233-1240. PubMed ID: 28350062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
    Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
    Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
    Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCRP1 is downregulated in non-small cell lung cancer and regulates proliferation, invasion, and drug resistance.
    Du Y; Wang P; Sun H; Yang J; Lang X; Wang Z; Zang S; Chen L; Ma J; Sun D
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27739029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased HCRP1 expression is associated with poor prognosis in breast cancer patients.
    Xu J; Yang W; Wang Q; Zhang Q; Li X; Lin X; Liu X; Qin Y
    Int J Clin Exp Pathol; 2014; 7(11):7915-22. PubMed ID: 25550832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.